Ninety One North America’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.02M Buy
6,689
+65
+1% +$66.4K 0.38% 56
2026
Q1
$6.09M Buy
6,624
+43
+0.7% +$43.6K 0.27% 55
2025
Q4
$7.07M Buy
+6,581
New +$6.29M 0.29% 55
2019
Q4
Sell
-19,441
Closed -$2.17M 108
2019
Q3
$2.17M Sell
19,441
-219
-1% -$24.4K 0.2% 59
2019
Q2
$2.18M Sell
19,660
-116,015
-86% -$13.7M 0.19% 69
2019
Q1
$17.6M Sell
135,675
-288
-0.2% -$35K 1.66% 27
2018
Q4
$15.7M Sell
135,963
-60,999
-31% -$6.81M 1.68% 29
2018
Q3
$21.1M Sell
196,962
-17,796
-8% -$1.78M 1.81% 28
2018
Q2
$18.3M Buy
214,758
+192,445
+862% +$15.8M 1.32% 31
2018
Q1
$1.73M Sell
22,313
-885
-4% -$71.2K 0.13% 94
2017
Q4
$1.96M Buy
+23,198
New +$1.97M 0.31% 53

Other funds holding LLY

Ninety One North America's LLY Position: Q2 2026 in Review

Ninety One North America increased its Eli Lilly (LLY) stake by 0.98% in Q2 2026, buying an estimated $66.4K and bringing the position to 6,689 shares worth $8.02M. The position accounts for 0.38% of the portfolio, ranked #56.

Ninety One North America first reported a position in LLY in Q4 2017 and has held it in 11 quarters since. The position peaked at $21.1M in Q3 2018. 1,615 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ninety One North America held 6,689 shares of Eli Lilly worth $8.02M as of Q2 2026.
  • Ninety One North America bought 65 Eli Lilly shares in Q2 2026, an estimated $66.4K.
  • Eli Lilly made up 0.38% of Ninety One North America's portfolio in Q2 2026, its #56 holding.
  • Ninety One North America first reported a position in Eli Lilly in Q4 2017 and has held it in 11 quarters since.
  • Ninety One North America's Eli Lilly position peaked at $21.1M in Q3 2018.
  • 1,615 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ninety One North America's 13F filing for Q2 2026, filed 16 Jul 2026.